Price T Rowe Associates Inc Haemonetics Corp Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 348,061 shares of HAE stock, worth $27.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

348,061

Previous 562,454 38.12%

Holding current value

$27.8 Million

Previous $48 Million 40.02%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $17.4 Million - $20.9 Million	-214,393 Reduced 38.12%	348,061 $28.8 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $11.2 Million - $13.4 Million	156,665 Added 38.61%	562,454 $48 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $9.21 Million - $10.6 Million	-114,335 Reduced 21.98%	405,789 $34.7 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $112,694 - $127,613	-1,365 Reduced 0.26%	520,124 $46.6 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $2.89 Million - $3.2 Million	35,733 Added 7.36%	521,489 $44.4 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $18,260 - $22,740	251 Added 0.05%	485,756 $40.2 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $5.87 Million - $6.85 Million	79,532 Added 19.59%	485,505 $38.2 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $5.59 Million - $6.95 Million	88,354 Added 27.82%	405,973 $30.1 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $1.64 Million - $2.2 Million	33,266 Added 11.7%	317,619 $20.7 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $1.75 Million - $2.53 Million	-40,007 Reduced 12.33%	284,353 $18 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $1.33 Million - $2.01 Million	-26,905 Reduced 7.66%	324,360 $17.2 Million
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $11.8 Million - $14.5 Million	-205,049 Reduced 36.86%	351,265 $24.8 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $219,778 - $502,931	4,242 Added 0.77%	556,314 $37.1 Million
Q1 2021 May 17, 2021	SELL	$111.01 - $139.48 $6.21 Million - $7.81 Million	-55,960 Reduced 9.2%	552,072 $61.3 Million
Q4 2020 Feb 16, 2021	BUY	$88.75 - $119.95 $54 Million - $72.9 Million	608,032 New	608,032 $72.2 Million

Others Institutions Holding HAE

# of Institutions

337

Shares Held

55.2M

Call Options Held

383K

Put Options Held

45.1K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.1B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Haemonetics Corp Transaction History